1
|
Lennon AM, Wolfgang CL, Canto MI, et al:
TThe early detection of pancreatic cancer: what will it take to
diagnose and treat curable pancreatic neoplasia? Cancer Res.
74:3381–3389. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kuroda T, Kumagi T, Yokota T, et al:
Improvement of long-term outcomes in pancreatic cancer and its
associated factors within the gemcitabine era: a collaborative
retrospective multicenter clinical review of 1,082 patients. BMC
Gastroenterol. 13:1342013. View Article : Google Scholar
|
3
|
Okitsu K, Kanda T, Imazeki F, Yonemitsu Y,
Ray RB, Chang C and Yokosuka O: Involvement of interleukin-6 and
androgen receptor signaling in pancreatic cancer. Genes Cancer.
1:859–867. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Miyazaki M, Yoshitomi H, Shimizu H, et al:
Repeat pancreatectomy for pancreatic ductal cancer recurrence in
the remnant pancreas after initial pancreatectomy: is it
worthwhile? Surgery. 155:58–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Sudo K, Ishihara T, Hirata N, et al:
Randomized controlled study of gemcitabine plus S-1 combination
chemotherapy versus gemcitabine for unresectable pancreatic cancer.
Cancer Chemother Pharmacol. 73:389–396. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Mahadevan NR, Rodvold J, Sepulveda H,
Rossi S, Drew AF and Zanetti M: Transmission of endoplasmic
reticulum stress and pro-inflammation from tumor cells to myeloid
cells. Proc Natl Acad Sci USA. 108:6561–6566. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Schroder M and Kaufman RJ: ER stress and
the unfolded protein response. Mutat Res. 569:29–63. 2005.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Hamanaka RB, Bennett BS, Cullinan SB and
Diehl JA: PERK and GCN2 contribute to eIF2α phosphorylation and
cell cycle arrest after activation of the unfolded protein response
pathway. Mol Biol Cell. 16:5493–5501. 2005.
|
9
|
Xu W, Liu L, Charles IG and Moncada S:
Nitric oxide induces coupling of mitochondrial signalling with the
endoplasmic reticulum stress response. Nat Cell Biol. 6:1129–1134.
2004. View
Article : Google Scholar : PubMed/NCBI
|
10
|
Ma Y and Hendershot LM: The role of the
unfolded protein response in tumour development: friend or foe? Nat
Rev Cancer. 4:966–977. 2004. View
Article : Google Scholar : PubMed/NCBI
|
11
|
Jiang X, Kanda T, Nakamoto S, Miyamura T,
Wu S and Yokosuka O: Involvement of androgen receptor and
glucose-regulated protein 78 kDa in human hepatocarcinogenesis. Exp
Cell Res. 323:326–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Shuda M, Kondoh N, Imazeki N, et al:
Activation of the ATF6, XBP1 and grp78 genes in human
hepatocellular carcinoma: a possible involvement of the ER stress
pathway in hepatocarcinogenesis. J Hepatol. 38:605–614. 2003.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Jiang X, Kanda T, Tanaka T, Wu S, Nakamoto
S, Imazeki F and Yokosuka O: Lipopolysaccharide blocks induction of
unfolded protein response in human hepatoma cell lines. Immunol
Lett. 152:8–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Martinon F and Glimcher LH: Regulation of
innate immunity by signaling pathways emerging from the endoplasmic
reticulum. Curr Opin Immunol. 23:35–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kanda T, Jiang X and Yokosuka O: Androgen
receptor signaling in hepatocellular carcinoma and pancreatic
cancers. World J Gastroenterol. 20:9229–9236. 2014.PubMed/NCBI
|
16
|
Nawrocki ST, Carew JS, Dunner K Jr, et al:
Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and
induces apoptosis via ER stress in human pancreatic cancer cells.
Cancer Res. 65:11510–11519. 2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Mujumdar N, Banerjee S, Chen Z, et al:
Triptolide activates unfolded protein response leading to chronic
ER stress in pancreatic cancer cells. Am J Physiol Gastrointest
Liver Physiol. 306:G1011–G1020. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Fu Y and Lee AS: Glucose regulated
proteins in cancer progression, drug resistance and immunotherapy.
Cancer Biol Ther. 5:741–744. 2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Lee E, Nichols P, Spicer D, Groshen S, Yu
MC and Lee AS: GRP78 as a novel predictor of responsiveness to
chemotherapy in breast cancer. Cancer Res. 66:7849–7853. 2006.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Kanda T, Yokosuka O, Imazeki F, Arai M and
Saisho H: Enhanced sensitivity of human hepatoma cells to
5-fluorouracil by small interfering RNA targeting Bcl-2. DNA
Cell Biol. 24:805–809. 2005. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ehrenfried JA, Herron BE, Townsend CM Jr
and Evers BM: Heat shock proteins are differentially expressed in
human gastrointestinal cancers. Surg Oncol. 4:197–203. 1995.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Tsai HY, Yang YF, Wu AT, et al:
Endoplasmic reticulum ribosome-binding protein 1 (RRBP1)
overexpression is frequently found in lung cancer patients and
alleviates intracellular stress-induced apoptosis through the
enhancement of GRP78. Oncogene. 32:4921–4931. 2013. View Article : Google Scholar
|
23
|
Visioli F, Wang Y, Alam GN, Ning Y, Rados
PV, Nör JE and Polverini PJ: Glucose-regulated protein 78 (Grp78)
confers chemoresistance to tumor endothelial cells under acidic
stress. PLoS One. 9:e1010532014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Roller C and Maddalo D: The molecular
chaperone GRP78/BiP in the development of chemoresistance:
mechanism and possible treatment. Front Pharmacol. 4:102013.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Soldani C and Scovassi AI:
Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update.
Apoptosis. 7:321–328. 2002. View Article : Google Scholar : PubMed/NCBI
|
26
|
Wang J, Yin Y, Hua H, et al: Blockade of
GRP78 sensitizes breast cancer cells to microtubules-interfering
agents that induce the unfolded protein response. J Cell Mol Med.
13:3888–3897. 2009. View Article : Google Scholar : PubMed/NCBI
|
27
|
Wang R, Shao F, Liu Z, et al: The Hsp90
inhibitor SNX-2112, induces apoptosis in multidrug resistant
K562/ADR cells through suppression of Akt/NF-κB and disruption of
mitochondria-dependent pathways. Chem Biol Interact. 205:1–10.
2013.PubMed/NCBI
|
28
|
Lei Y, Henderson BR, Emmanuel C, Harnett
PR and Defazio A: Inhibition of ANKRD1 sensitizes human ovarian
cancer cells to endoplasmic reticulum stress-induced apoptosis.
Oncogene. Feb 17–2014.(Epub ahead of print).
|